These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20659396)

  • 1. Evaluation of electro-eluted antigens in the serological diagnosis of cutaneous leishmaniasis.
    Castellano LR; Gave TC; Lira MA; Dessein H; Dessein A; Correia D; Rodrigues V
    Ann Trop Med Parasitol; 2010 Jun; 104(4):347-50. PubMed ID: 20659396
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs.
    Ribeiro FC; de O Schubach A; Mouta-Confort E; Schubach TM; de Fátima Madeira M; Marzochi MC
    Vet Parasitol; 2007 Sep; 148(3-4):200-6. PubMed ID: 17689193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of an ELISA and indirect immunofluorescence for the laboratory diagnosis of American tegumentary leishmaniasis.
    Barroso-Freitas AP; Passos SR; Mouta-Confort E; Madeira MF; Schubach AO; Santos GP; Nascimento LD; Marzochi MC; Marzochi KB
    Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):383-9. PubMed ID: 19211118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potentially diagnostic Leishmania braziliensis antigens in human cutaneous leishmaniasis by immunoblot analysis.
    Brito ME; Mendonça MG; Gomes YM; Jardim ML; Abath FG
    Clin Diagn Lab Immunol; 2000 Mar; 7(2):318-21. PubMed ID: 10702514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical and immunohistochemical methods as auxiliary techniques for histopathological diagnosis of cutaneous leishmaniasis.
    Lunedo SN; Thomaz-Soccol V; de Castro EA; Telles JE
    Acta Histochem; 2012 May; 114(3):252-8. PubMed ID: 21742368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High performance of an enzyme linked immunosorbent assay for American tegumentary leishmaniasis diagnosis with Leishmania (Viannia) braziliensis amastigotes membrane crude antigens.
    Bracamonte ME; Álvarez AM; Sosa AM; Hoyos CL; Lauthier JJ; Cajal SP; Juarez M; Uncos RE; Sánchez-Valdéz FJ; Acuña L; Diosque P; Basombrío MA; Nasser JR; Hashiguchi Y; Korenaga M; Barroso PA; Marco JD
    PLoS One; 2020; 15(5):e0232829. PubMed ID: 32379842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the specificity of human antibodies to antigens of Leishmania braziliensis braziliensis.
    Masuda A; do Nascimento SF; Guerra CS; Paranhos Gda S; Ferreira AW
    Rev Inst Med Trop Sao Paulo; 1989; 31(4):228-34. PubMed ID: 2626643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis.
    Valli LC; Passos VM; Dietze R; Callahan HL; Berman JD; Grogl M
    J Parasitol; 1999 Dec; 85(6):1076-83. PubMed ID: 10647040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a hypothetical protein for serodiagnosis and as a potential marker for post-treatment serological evaluation of tegumentary leishmaniasis patients.
    Lima MP; Costa LE; Duarte MC; Menezes-Souza D; Salles BCS; de Oliveira Santos TT; Ramos FF; Chávez-Fumagalli MA; Kursancew ACS; Ambrósio RP; Roatt BM; Machado-de-Ávila RA; Gonçalves DU; Coelho EAF
    Parasitol Res; 2017 Apr; 116(4):1197-1206. PubMed ID: 28150041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenicity of Leishmania braziliensis histone H1 during cutaneous leishmaniasis: localization of antigenic determinants.
    Carmelo E; Martínez E; González AC; Piñero JE; Patarroyo ME; Del Castillo A; Valladares B
    Clin Diagn Lab Immunol; 2002 Jul; 9(4):808-11. PubMed ID: 12093677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme immunoassay using Leishmania (Viannia) braziliensis antigens for laboratorial diagnosis of American cutaneous leishmaniasis.
    Vidigal Cde P; Marcussi VM; Marcussi LM; Mikcha JM; Arraes SM; Lonardoni MV; Silveira TG
    Acta Trop; 2008 Aug; 107(2):208-12. PubMed ID: 18561892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis.
    Carvalho EM; Correia Filho D; Bacellar O; Almeida RP; Lessa H; Rocha H
    Am J Trop Med Hyg; 1995 Sep; 53(3):273-7. PubMed ID: 7573712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Peptides as Potential Antigens for Cutaneous Leishmaniosis Diagnosis.
    Link JS; Alban SM; Soccol CR; Pereira GV; Thomaz Soccol V
    J Immunol Res; 2017; 2017():5871043. PubMed ID: 28367456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of American cutaneous leishmaniasis by enzyme immunoassay using membrane antigens of Leishmania (Viannia) braziliensis.
    Skraba CM; Pedroso RB; Fiorini A; Rosado FR; Aristides SM; Lonardoni MV; Teixeira JJ; Silveira TG
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):411-7. PubMed ID: 24485589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of three ELISA tests using promastigote homogenates of Leishmania braziliensis, L. amazonensis and L. guyanensis in the diagnosis of tegumentary leishmaniasis].
    Gil JF; Hoyos CL; Cimino RO; Krolewiecki AJ; López Quiroga I; Cajal SP; Juárez M; García Bustos MF; Mora MC; Marco JD; Nasser JR
    Medicina (B Aires); 2011; 71(5):420-8. PubMed ID: 22057166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serological investigation of subclinical cutaneous leishmaniasis cases following an outbreak in an endemic area].
    Arraes SM; Marini MT; Martello D; Silveira TG; Lonardoni MV; Nanni MR
    Rev Soc Bras Med Trop; 2008; 41(2):205-8. PubMed ID: 18545847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montenegro's skin reactions and antibodies against different Leishmania species in dogs from a visceral leishmaniosis endemic area.
    Baleeiro CO; Paranhos-Silva M; dos Santos JC; Oliveira GG; Nascimento EG; de Carvalho LP; dos-Santos WL
    Vet Parasitol; 2006 Jun; 139(1-3):21-8. PubMed ID: 16567046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of Enzyme-Linked Immunosorbent Assays to detect anti-Leishmania antibodies in patients with American Tegumentary Leishmaniasis: a systematic review.
    Zanetti ADS; Sato CM; Longhi FG; Ferreira SMB; Espinosa OA
    Rev Inst Med Trop Sao Paulo; 2019 Aug; 61():e42. PubMed ID: 31432991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serological and parasitological methods for cutaneous leishmaniasis diagnosis in the state of Paraná, Brazil.
    Szargiki R; Castro EA; Luz E; Kowalthuk W; Machado AM; Thomaz-Soccol V
    Braz J Infect Dis; 2009 Feb; 13(1):47-52. PubMed ID: 19578630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.